• Background: Excessive alcohol consumption is a primary cause of alcoholic liver disease (ALD), accounting for a 4% morbidity and mortality rate. ALD involves several disease stages and is characterized by sustained hepatic inflammation, oxidative...
参考文献 1.Zayed Rashid et al. Impact of Glucagon-like Peptide-1 Receptor Agonists on the Risk of Adverse Liver Outcomes among Patients with Alcohol-associated Liver Disease and Type 2 Diabetes. AASLD 2024 Oral No. 0009 2. Shiv Kumar Sarin et al. Fecal Microbiota Therapy is a safe and eff...
参考文献 1.Zayed Rashid et al. Impact of Glucagon-like Peptide-1 Receptor Agonists on the Risk of Adverse Liver Outcomes among Patients with Alcohol-associated Liver Disease and Type 2 Diabetes. AASLD 2024 Oral No. 0009 2. Shiv Kumar Sarin et al. Fecal Microbiota Therapy is a safe and eff...
终末期肝病模型(model for end-stage liver disease,MELD)3.0对终末期肝病患者死亡率的预测作用良好。然而,其在酒精性肝病(alcohol- related liver disease,ARLD)患者死亡率方面的预测价值并未被评估。本研究旨在评估MELD 3.0对ARLD患者...
在中国,酒精性肝病(alcohol- related liver disease,ARLD)的疾病负担不断增加。ARLD患者更易合并肌肉减少症,这可能影响ARLD患者的生存。肌少症与中国ARLD患者预后的关系尚不明确。本研究旨在通过第三腰椎水平的骨骼肌指数(skeletal muscle index at the third lumbar vertebra level,L3-SMI)评估ARLD患者的预后与肌...
1. Yee Hui Yeo, et al. The Development, Feasibility, and Usability of an Artificial Intelligence-Enabled Conversational Agent in Virtual Reality for Patients with Alcohol-Associated Cirrhosis. AASLD 2024 No. 3145 2. Yee Hui Yeo, et al. The Impact of Concurrent Chronic Hepatitis B Infection on...
this disease. Possible factors that affect the development of liver injury include the dose, duration, and type of alcohol consumption; drinking patterns; sex; ethnicity; and asso-ciated risk factors including obesity, iron overload, con-comitant infection with viral hepatitis, and genetic factors...
3580-C: NOVEL CIRCULATING EXOSOMAL MIRNAS AND mRNA NETWORK OFFERS PATHOPHYSIOLOGIC INSIGHTS AND POTENTIAL FOR NEW BIOMARKER DISCOVERY AND THERAPEUTIC TARGETS IN PATIENTS WITH SEVERE ALCOHOL ASSOCIATED HEPATITIS (SAH) 第一作者:曾静;通讯作者:Huiping Zhou,Puneet Puri ...
酒精时间表跟踪评估（Alcohol Timeline Follow-back assessment）是目前跟踪饮酒量的“最佳实践”，但需要对人员进行特定的培训[24]。可以考虑在长期试验的背景下评估其如何影响试验结果。安慰剂反应（Placebo Response）: 试验成功的一个关键决定因素 最终，研究化合物的疗效是否优于安慰剂决定了干预的成功与否。丙型肝炎...
参考文献: Xie W, Cao LH, Dang SS, et al. Non-Alcohol Fatty Liver Disease In A Prospective National Cohort Of Hepatitis B Patients With Suboptimal Response To Antiviral Therapy [J]. AASLD2023, Abstracts (1371-C). 发布于 2024-01-05 18:14・IP 属地北京 ...